P3 Health Partners Inc.
PIII Healthcare Medical Care Facilities
P3 Health Partners Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 2.76% from fiscal 2024. In the quarter to June 2026, revenue grew 8.60%, EPS grew 89.9%, free cash flow fell 272.2% and total debt fell 34.1%, each against the same quarter a year earlier.
Follow PIII
P3 Health Partners Inc. (PIII) P/E ratio
P3 Health Partners Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 18 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| DCGO DocGo Inc. compare | n/m |
| PARK Park Dental Partners, Inc. compare | n/m |
| CCM Concord Medical Services Holdings Limited compare | n/m |
| AIRS AirSculpt Technologies, Inc. compare | n/m |
| PIII P3 Health Partners Inc. | n/m |
| PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR compare | n/m |
| CCEL Cryo-Cell International Inc. compare | n/m |
| BTMD biote Corp. compare | 6.8× |
| JYNT The Joint Corp. compare | 26.0× |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)